elisa human proprotein convertase 9 pcsk9 quantikine elisa kit (R&D Systems)
Structured Review
Elisa Human Proprotein Convertase 9 Pcsk9 Quantikine Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 93 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/quantikine+elisa+kit/Human+Proprotein+Convertase+9%2FPCSK9+Quantikine+ELISA+Kit/pmc13091390-93-23-31
Average 95 stars, based on 93 article reviews
Images
Related Articles
Biomarker Discovery:Article Title: Diagnostic Accuracy and Clinical Utility of Salivary Biomarkers in Oral Squamous Cell Carcinoma: A Meta-Analysis. Article Snippet: .. First Author Year Country Study Design Sample Size Biomarker Evaluated Detection Platform Normalization/ Internal ControlOSCC Control Total Wan et al. [32] 2017 Australia Case Control 47 113 163 miR–9, miR–127, miR–134, miR–191, miR–222, and miR–455 RT–qPCR SNORD96A Duz et al. [33] 2016 Turkey Case Control 24 25 49 miR–139–5p microarray andRT–qPCR Single RNU6B Ghallab et al. [34] 2016 Egypt Case Control 15 15 30 Chemerin MMP-9: Control:Article Title: Diagnostic Accuracy and Clinical Utility of Salivary Biomarkers in Oral Squamous Cell Carcinoma: A Meta-Analysis. Article Snippet: .. First Author Year Country Study Design Sample Size Biomarker Evaluated Detection Platform Normalization/ Internal ControlOSCC Control Total Wan et al. [32] 2017 Australia Case Control 47 113 163 miR–9, miR–127, miR–134, miR–191, miR–222, and miR–455 RT–qPCR SNORD96A Duz et al. [33] 2016 Turkey Case Control 24 25 49 miR–139–5p microarray andRT–qPCR Single RNU6B Ghallab et al. [34] 2016 Egypt Case Control 15 15 30 Chemerin MMP-9: Microarray:Article Title: Diagnostic Accuracy and Clinical Utility of Salivary Biomarkers in Oral Squamous Cell Carcinoma: A Meta-Analysis. Article Snippet: .. First Author Year Country Study Design Sample Size Biomarker Evaluated Detection Platform Normalization/ Internal ControlOSCC Control Total Wan et al. [32] 2017 Australia Case Control 47 113 163 miR–9, miR–127, miR–134, miR–191, miR–222, and miR–455 RT–qPCR SNORD96A Duz et al. [33] 2016 Turkey Case Control 24 25 49 miR–139–5p microarray andRT–qPCR Single RNU6B Ghallab et al. [34] 2016 Egypt Case Control 15 15 30 Chemerin MMP-9: Enzyme-linked Immunosorbent Assay:Article Title: Diagnostic Accuracy and Clinical Utility of Salivary Biomarkers in Oral Squamous Cell Carcinoma: A Meta-Analysis. Article Snippet: .. First Author Year Country Study Design Sample Size Biomarker Evaluated Detection Platform Normalization/ Internal ControlOSCC Control Total Wan et al. [32] 2017 Australia Case Control 47 113 163 miR–9, miR–127, miR–134, miR–191, miR–222, and miR–455 RT–qPCR SNORD96A Duz et al. [33] 2016 Turkey Case Control 24 25 49 miR–139–5p microarray andRT–qPCR Single RNU6B Ghallab et al. [34] 2016 Egypt Case Control 15 15 30 Chemerin MMP-9: Article Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy Article Snippet: .. Production of IFN-γ was measured using Article Title: Ethanolic Extract of Padina arborescens Suppresses Melanogenesis and Attenuates UVB-Induced Photodamage in Cellular and Zebrafish Models Article Snippet: .. After 24 h of incubation, culture supernatants were collected, and human IL-1β levels were measured using the Article Title: From bats to humans: uncovering ISG15 as a new resistance factor in type 1 diabetes Article Snippet: .. Human CXCL10/IP-10 Immunoassay ( Article Title: Doxorubicin enhances adipogenesis in an FGF2-dependent manner and induces a tumour-promoting secretory phenotype Article Snippet: .. ELISA to measure protein concentration of FGF2 in conditioned supernatants was performed using the Article Title: INTERLEUKIN-1 RECEPTOR ANTAGONIST LEVELS IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION TREATED WITH ANAKINRA Article Snippet: .. Plasma samples were analyzed using enzyme-linked immunosorbent assay ( Article Title: The role of S100A8/A9 in the pathogenesis of acute exacerbations of pulmonary fibrosis. Article Snippet: .. 140 DuoSet ELISA Kit (R&D Systems, Minneapolis, MN, USA) was used to detect S100A8/A9 141 levels (both human and mouse), whereas the Article Title: Plasma biomarker‐informed brain topology for cognitive resilience: applications in non‐pharmacological interventions concerning cognitive aging Article Snippet: .. For a proportion of ACT participants, we measured plasma p‐tau 217 using an ALZpath Simoa® p‐tau217 version 2 Assay Kit (Lot No. 999024, MAB031022) on an HD‐X analyzer (Quanterix, MA, USA), plasma GFAP, NfL, Aβ 1‐42 using the Quanterix Neurology 4 plex assay E (N4PE) kit (Lot No. 503940) on an HD‐X analyzer (Quanterix), and serum free‐BDNF using a Reverse Transcription:Article Title: Diagnostic Accuracy and Clinical Utility of Salivary Biomarkers in Oral Squamous Cell Carcinoma: A Meta-Analysis. Article Snippet: .. First Author Year Country Study Design Sample Size Biomarker Evaluated Detection Platform Normalization/ Internal ControlOSCC Control Total Wan et al. [32] 2017 Australia Case Control 47 113 163 miR–9, miR–127, miR–134, miR–191, miR–222, and miR–455 RT–qPCR SNORD96A Duz et al. [33] 2016 Turkey Case Control 24 25 49 miR–139–5p microarray andRT–qPCR Single RNU6B Ghallab et al. [34] 2016 Egypt Case Control 15 15 30 Chemerin MMP-9: Real-time Polymerase Chain Reaction:Article Title: Diagnostic Accuracy and Clinical Utility of Salivary Biomarkers in Oral Squamous Cell Carcinoma: A Meta-Analysis. Article Snippet: .. First Author Year Country Study Design Sample Size Biomarker Evaluated Detection Platform Normalization/ Internal ControlOSCC Control Total Wan et al. [32] 2017 Australia Case Control 47 113 163 miR–9, miR–127, miR–134, miR–191, miR–222, and miR–455 RT–qPCR SNORD96A Duz et al. [33] 2016 Turkey Case Control 24 25 49 miR–139–5p microarray andRT–qPCR Single RNU6B Ghallab et al. [34] 2016 Egypt Case Control 15 15 30 Chemerin MMP-9: Next-Generation Sequencing:Article Title: Diagnostic Accuracy and Clinical Utility of Salivary Biomarkers in Oral Squamous Cell Carcinoma: A Meta-Analysis. Article Snippet: .. First Author Year Country Study Design Sample Size Biomarker Evaluated Detection Platform Normalization/ Internal ControlOSCC Control Total Wan et al. [32] 2017 Australia Case Control 47 113 163 miR–9, miR–127, miR–134, miR–191, miR–222, and miR–455 RT–qPCR SNORD96A Duz et al. [33] 2016 Turkey Case Control 24 25 49 miR–139–5p microarray andRT–qPCR Single RNU6B Ghallab et al. [34] 2016 Egypt Case Control 15 15 30 Chemerin MMP-9: Chromatography:Article Title: Diagnostic Accuracy and Clinical Utility of Salivary Biomarkers in Oral Squamous Cell Carcinoma: A Meta-Analysis. Article Snippet: .. First Author Year Country Study Design Sample Size Biomarker Evaluated Detection Platform Normalization/ Internal ControlOSCC Control Total Wan et al. [32] 2017 Australia Case Control 47 113 163 miR–9, miR–127, miR–134, miR–191, miR–222, and miR–455 RT–qPCR SNORD96A Duz et al. [33] 2016 Turkey Case Control 24 25 49 miR–139–5p microarray andRT–qPCR Single RNU6B Ghallab et al. [34] 2016 Egypt Case Control 15 15 30 Chemerin MMP-9: Targeted Proteomics:Article Title: Diagnostic Accuracy and Clinical Utility of Salivary Biomarkers in Oral Squamous Cell Carcinoma: A Meta-Analysis. Article Snippet: .. First Author Year Country Study Design Sample Size Biomarker Evaluated Detection Platform Normalization/ Internal ControlOSCC Control Total Wan et al. [32] 2017 Australia Case Control 47 113 163 miR–9, miR–127, miR–134, miR–191, miR–222, and miR–455 RT–qPCR SNORD96A Duz et al. [33] 2016 Turkey Case Control 24 25 49 miR–139–5p microarray andRT–qPCR Single RNU6B Ghallab et al. [34] 2016 Egypt Case Control 15 15 30 Chemerin MMP-9: Multiplex sample analysis:Article Title: Diagnostic Accuracy and Clinical Utility of Salivary Biomarkers in Oral Squamous Cell Carcinoma: A Meta-Analysis. Article Snippet: .. First Author Year Country Study Design Sample Size Biomarker Evaluated Detection Platform Normalization/ Internal ControlOSCC Control Total Wan et al. [32] 2017 Australia Case Control 47 113 163 miR–9, miR–127, miR–134, miR–191, miR–222, and miR–455 RT–qPCR SNORD96A Duz et al. [33] 2016 Turkey Case Control 24 25 49 miR–139–5p microarray andRT–qPCR Single RNU6B Ghallab et al. [34] 2016 Egypt Case Control 15 15 30 Chemerin MMP-9: Incubation:Article Title: Ethanolic Extract of Padina arborescens Suppresses Melanogenesis and Attenuates UVB-Induced Photodamage in Cellular and Zebrafish Models Article Snippet: .. After 24 h of incubation, culture supernatants were collected, and human IL-1β levels were measured using the Protein Concentration:Article Title: Doxorubicin enhances adipogenesis in an FGF2-dependent manner and induces a tumour-promoting secretory phenotype Article Snippet: .. ELISA to measure protein concentration of FGF2 in conditioned supernatants was performed using the Clinical Proteomics:Article Title: INTERLEUKIN-1 RECEPTOR ANTAGONIST LEVELS IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION TREATED WITH ANAKINRA Article Snippet: .. Plasma samples were analyzed using enzyme-linked immunosorbent assay ( Article Title: Plasma biomarker‐informed brain topology for cognitive resilience: applications in non‐pharmacological interventions concerning cognitive aging Article Snippet: .. For a proportion of ACT participants, we measured plasma p‐tau 217 using an ALZpath Simoa® p‐tau217 version 2 Assay Kit (Lot No. 999024, MAB031022) on an HD‐X analyzer (Quanterix, MA, USA), plasma GFAP, NfL, Aβ 1‐42 using the Quanterix Neurology 4 plex assay E (N4PE) kit (Lot No. 503940) on an HD‐X analyzer (Quanterix), and serum free‐BDNF using a Plex Assay:Article Title: Plasma biomarker‐informed brain topology for cognitive resilience: applications in non‐pharmacological interventions concerning cognitive aging Article Snippet: .. For a proportion of ACT participants, we measured plasma p‐tau 217 using an ALZpath Simoa® p‐tau217 version 2 Assay Kit (Lot No. 999024, MAB031022) on an HD‐X analyzer (Quanterix, MA, USA), plasma GFAP, NfL, Aβ 1‐42 using the Quanterix Neurology 4 plex assay E (N4PE) kit (Lot No. 503940) on an HD‐X analyzer (Quanterix), and serum free‐BDNF using a |
![circSMAD4 drives tumor-educated M2-like polarization of macrophages and promotes tumor-cell aggressiveness. (A) Workflow for generating TC-hMDMs and TC-BMDMs, circSMAD4 knockdown, and downstream functional assays. (B) RT–qPCR analysis of M1-associated markers (MHC-II [HLA-DRA in TC-hMDMs; H2-Ab1 in TC-BMDMs], NOS2, and CD86) and M2-associated markers (CD163, CD206, and ARG1) in TC-hMDMs and TC-BMDMs. (C) Representative flow-cytometry histograms for HLA-DR, iNOS, CD86, CD163, CD206, and ARG1 in TC-hMDMs. Gating strategy and marker thresholds were defined based on FMO controls (see ). (D) Flow-cytometry quantification of marker-positive cells in TC-hMDMs and TC-BMDMs. (E) ELISA of <t>IL-10,</t> TGF-β, and iNOS in culture supernatants. (F) CCK-8 assays of A549 and LLC cells. (G) Colony-formation assays of A549 and LLC cells with quantification. (H) Bioluminescence-based growth readouts of patient-derived LUAD organoids (PDO #1 and PDO #2) after co-culture with TC-hMDMs. (I) Immunoblot analysis of EMT-related proteins (E-cadherin, N-cadherin, Vimentin) in A549 and LLC cells. (J) Transwell migration and invasion assays of A549 and LLC cells with quantification. Scale bar, 50 μm. ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001; ∗∗∗∗P < 0.0001; ns, not significant.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_0104/pmc13050104/pmc13050104__gr2.jpg)